These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17402690)

  • 1. [Portopulmonary hypertension due to schistosomiasis in two Malagasy patients].
    Ramanampamonjy RM; Razafimahefa SH; Rajaonarivelo P; Rajaona HR
    Bull Soc Pathol Exot; 2007 Feb; 100(1):28-9. PubMed ID: 17402690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
    Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
    Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portopulmonary hypertension and right heart failure in patients with cirrhosis.
    Ramsay M
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):145-50. PubMed ID: 20124995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epoprostenol in the treatment of portopulmonary hypertension].
    Culafić D; Culafić-Vojinović V; Jesić R
    Srp Arh Celok Lek; 2003; 131(5-6):271-4. PubMed ID: 14692137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful management of portopulmonary hypertension with beraprost.
    Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation between Shistosoma mansoni and hepatosplenomegalies].
    Rakotonirina EJ; Andrianjaka P; Rakotoarivelo RA; Ramanampamonjy RM; Randria MJ; Rakotomanga JD
    Sante; 2010; 20(1):15-9. PubMed ID: 20350861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of pulmonary hypertension in patients with hepatosplenic Mansonic schistosomiasis--prospective study.
    de Cleva R; Herman P; Pugliese V; Zilberstein B; Saad WA; Rodrigues JJ; Laudanna AA
    Hepatogastroenterology; 2003; 50(54):2028-30. PubMed ID: 14696458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portopulmonary hypertension.
    Mukhtar NA; Fix OK
    J Clin Gastroenterol; 2011 Sep; 45(8):703-10. PubMed ID: 21325952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary hypertension complicating portal hypertension: portopulmonary hypertension].
    Katsuta Y; Zhang XJ; Aramaki T
    Nihon Rinsho; 2001 Jun; 59(6):1186-92. PubMed ID: 11411134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperdynamic circulation in Manson's hepatosplenic schistosomiasis].
    de Cleva R; Pugliese V; Zilberstein B; Saad WA; Pinotti HW; Laudanna AA
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(1):6-10. PubMed ID: 9659736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perioperative management of living-donor liver transplantation in two patients with severe portopulmonary hypertension].
    Tominaga M; Furutani H; Segawa H; Shoda T; Mima H; Adachi T; Fukuda K
    Masui; 2003 Jul; 52(7):729-32. PubMed ID: 12910972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal hypertension due to hepatosplenic schistosomiasis: a case report and review of the literature.
    Eyres KS; Kantharia B; Magides AD; Ali HH; MacDonald RC
    Br J Clin Pract; 1991; 45(2):146-7. PubMed ID: 1793702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of portal hypertension in hepatosplenic schistosomiasis.
    el-Hawey AM; Abou-Taleb SA; el-Gammal HA; Abdel-Rahman MM; Sabry AA
    J Egypt Soc Parasitol; 1992 Aug; 22(2):305-9. PubMed ID: 1500767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 25-year clinical history of portopulmonary hypertension associated with latent myeloproliferative disorder.
    Ito H; Adachi Y; Arimura Y; Endo T; Hinoda Y; Imai K
    J Gastroenterol; 2003; 38(5):488-92. PubMed ID: 12768393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation.
    Kett DH; Acosta RC; Campos MA; Rodriguez MJ; Quartin AA; Schein RM
    Liver Transpl; 2001 Jul; 7(7):645-8. PubMed ID: 11460234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vascular disease associated with schistosomiasis.
    Kolosionek E; Crosby A; Harhay MO; Morrell N; Butrous G
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1467-73. PubMed ID: 21133670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible pulmonary hypertension, tricuspid regurgitation and right-sided heart failure associated with hyperthyroidism: case report and review of the literature.
    Lozano HF; Sharma CN
    Cardiol Rev; 2004; 12(6):299-305. PubMed ID: 15476566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid normalization of portopulmonary hypertension after living donor liver transplantation.
    Sugimachi K; Soejima Y; Morita K; Ueda S; Fukuhara T; Nagata S; Ikegami T; Taketomi A; Maehara Y
    Transplant Proc; 2009 Jun; 41(5):1976-8. PubMed ID: 19545772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
    Fix OK; Bass NM; De Marco T; Merriman RB
    Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension and right-sided heart failure in an adult llama with hepatic disease.
    Middleton JR; Chigerwe M; Fine DM; Turk JR; Lattimer JC
    J Am Vet Med Assoc; 2006 Mar; 228(5):756-9. PubMed ID: 16506943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.